The management of extracorporeal carbon dioxide removal device in a diffuse alveolar haemorrhage.

摘要

In patients with acute respiratory distress syndrome (ARDS), tidal hyperinflation may occur despite limiting tidal volume and plateau pressure, strategies associated with hypercapnoea and respiratory acidosis1'2. Adjunctive therapies such as veno-venous carbon dioxide removal (VVCO2R), allow for CO2 homeostasis associated with protective ventilation, gaining time for lung recovery3. Anticoagulation is necessary for the optimal efficiency of such devices, this being a challenge when it is contraindicated such as in haemorrhagic conditions4. We report the anticoagulation management with pump-driven WCO2R following ARDS in a patient with diffuse alveolar haemorrhage. Patient consent was obtained prior to presenting the following information.